Could Ozempic Help Treat Substance Use Disorder? This Expert Is Hopeful
More than 48 million Americans 12 years or older had a substance use disorder in 2022, yet only 24 percent received treatment ...
kffhealthnews1d
Semaglutide Appears To Aid People With Alcohol Use Disorder, Study Says
Meanwhile, Hims & Hers tackles the GLP-1 shortage with a new app; Eli Lilly releases data on tirzepatide efficacy; 23andMe faces privacy concerns; and more.
Comparing Oral vs. Injectable Semaglutide: Is One More Effective Than the Other?
It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...
Endocrinology Advisor1d
Novo Nordisk CEO Warns of Deaths Linked to Compounded Semaglutide
The head of the company that makes the diabetes and obesity drugs Ozempic and Wegovy has warned that compounded versions of the active ingredient in those medications have now been linked to at least ...
Medscape1d
GLP-1 Prescribing Decisions: Compounded or Brand-Name?
With brand-name GLP-1s for obesity treatment on and off the shortage list, prescribing can get complicated. Five providers ...